ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 267 filers reported holding ALKERMES PLC in Q4 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,410,000 | -62.4% | 97,800 | -46.8% | 0.75% | +70.6% |
Q4 2019 | $3,749,000 | +4.6% | 183,800 | 0.0% | 0.44% | -4.1% |
Q3 2019 | $3,585,000 | -26.1% | 183,800 | -14.6% | 0.46% | +36.3% |
Q2 2019 | $4,852,000 | -38.2% | 215,300 | 0.0% | 0.34% | -7.7% |
Q1 2019 | $7,856,000 | +137.9% | 215,300 | +92.4% | 0.36% | +59.6% |
Q4 2018 | $3,302,000 | +408.8% | 111,900 | +631.4% | 0.23% | +516.2% |
Q3 2018 | $649,000 | +3.2% | 15,300 | 0.0% | 0.04% | 0.0% |
Q2 2018 | $629,000 | -74.6% | 15,300 | -68.6% | 0.04% | -72.2% |
Q3 2017 | $2,480,000 | -12.3% | 48,800 | 0.0% | 0.13% | -24.0% |
Q2 2017 | $2,828,000 | -34.9% | 48,800 | -34.3% | 0.18% | -36.4% |
Q1 2017 | $4,346,000 | +60.6% | 74,300 | +52.6% | 0.28% | +23.9% |
Q4 2016 | $2,706,000 | +200.0% | 48,700 | +84.5% | 0.22% | +144.0% |
Q1 2016 | $902,000 | +219.9% | 26,400 | +214.3% | 0.09% | +42.2% |
Q3 2013 | $282,000 | -58.8% | 8,400 | -64.9% | 0.06% | -65.0% |
Q2 2013 | $685,000 | – | 23,900 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |